Nurse Practitioner, Adult Health · Ithaca, NY
NPI
1700448503
Since 2019
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
1301 Trumansburg Rd Ste P
Ithaca, NY, 14850
Phone (607) 277-2365
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
381 services
Medicare patients, 2024
229
Average age 71
Drug cost, 2024
$329K
1,111 prescriptions
Company payments, 2025
$192
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Emily R Dvorak was code 99214 (office e&m - established), 193 times for 143 patients. In total Emily R Dvorak billed 381 services in 10 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-07-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 193 | 143 | $77.07 | $15K |
| 99213 Office E&M - Established | Office | 91 | 78 | $50.88 | $4,630 |
| 99204 Office E&M - New | Office | 52 | 52 | $103.48 | $5,381 |
| 99215 Office E&M - Established | Office | 31 | 28 | $110.27 | $3,418 |
By year: 2022 $15K for 242 services; 2023 $23K for 351 services; 2024 $29K for 381 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82272 Immunoassay | 11 | 11 | $4.15 | $45.65 |
Medicare prescription drug claims, 2024
In 2024, the drug Emily R Dvorak prescribed most often to Medicare patients was Omeprazole, with 206 prescriptions and refills. In total Emily R Dvorak wrote 1,111 Medicare prescriptions that cost $329K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Omeprazole Generic | 206 | 494 | 89 | $2,543 |
| Esomeprazole Magnesium Generic | 131 | 245 | 36 | $10K |
| Famotidine Generic | 96 | 235 | 45 | $937 |
| Lubiprostone Generic | 76 | 114 | 24 | $21K |
| Linzess Linaclotide | 72 | 138 | 34 | $71K |
| Peg-3350 And Electrolytes Peg3350/Sod Sulf,bicarb,cl/Kcl | 68 | 68 | 64 | $804 |
| Pantoprazole Sodium Generic | 53 | 133 | 26 | $761 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 47 | 47 | 45 | $2,774 |
| Clenpiq Sod Picosulf/Mag Ox/Citric Ac | 32 | 32 | 32 | $5,452 |
| Ondansetron Odt Ondansetron | 29 | 29 | 18 | $208 |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 29 | 29 | 28 | $322 |
| Rabeprazole Sodium Generic | 13 | 39 | Under 11 | $2,310 |
| Xifaxan Rifaximin | 13 | 13 | 12 | $29K |
| Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine | 12 | 12 | Under 11 | $462 |
| Colestipol Hcl Generic | 12 | 14 | Under 11 | $695 |
Brand drugs: 310 claims; generic drugs: 801 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Emily R Dvorak $192 ($192 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $156.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 5 | $156 |
| QOL Medical, LLC | 1 | $35.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.